Time delay of baroreflex control and oscillatory pattern of sympathetic activity in patients with metabolic syndrome and obstructive sleep apnea

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 304, Issue 7, 2013, Pages

  Toschi Dias, Edgar ^a   Trombetta, Ivani C ^a   Dias da Silva, Valdo J ^b   Maki Nunes, Cristiane ^a   Cepeda, Felipe X ^a   Alves, Maria Janieire N N ^a   Drager, Luciano F ^a   Lorenzi Filho, Geraldo ^a   Negrao, Carlos E ^a   Rondon, Maria Urbana P B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Heart rate variability; Latency of baroreflex control; Muscle sympathetic nerve activity variability

Indexed keywords

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTERIAL BAROREFLEX CONTROL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HUMAN; MALE; METABOLIC SYNDROME X; MUSCLE SYMPATHETIC NERVE ACTIVITY; NERVOUS SYSTEM PARAMETERS; NEUROGRAPHY; OSCILLATION; POLYSOMNOGRAPHY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SPECTROSCOPY; TIME DELAY;

ADULT; BAROREFLEX; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYSOMNOGRAPHY; REACTION TIME; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84878547240     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00848.2012     Document Type: Article

References (40)

1. Baselli G, Cerutti S, Civardi S, Malliani A, Pagani M. Cardiovascular variability signals: towards the identification of a closed-loop model of the neural control mechanisms. IEEE Trans Biomed Eng 35: 1033-1046, 1988.
2. Bertram D, Barrès C, Cheng Y, Julien C. Norepinephrine reuptake, baroreflex dynamics, and arterial pressure variability in rats. Am J Physiol Regul Integr Comp Physiol 279: R1257-R1267, 2000.
3. Cevese A, Gulli G, Polati E, Gottin L, Grasso R. Baroreflex and oscillation of heart period at 0.1 Hz studied by alpha-blockade and cross-spectral analysis in healthy humans. J Physiol 531: 235-244, 2001.
4. Cogliati C, Colombo S, Ruscone TG, Gruosso D, Porta A, Montano N, Malliani A, Furlan R. Acute beta-blockade increases muscle sympathetic activity and modifies its frequency distribution. Circulation 110: 2786-2791, 2004.
5. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112: 666-673, 2005.
6. Drager LF, Bortolotto LA, Krieger EM, Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 53: 64-69, 2009.
7. Drager LF, Bortolotto LA, Maki-Nunes C, Trombetta IC, Alves MJ, Fraga RF, Negrão CE, Krieger EM, Lorenzi-Filho G. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 208: 490-495, 2010.
8. Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ, Fraga RF, Jung JC, Negrão CE, Krieger EM, Polotsky VY, Lorenzi-Filho G. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS One 5: e12065, 2010.
9. Fisher JP, Kim A, Young CN, Ogoh S, Raven PB, Secher NH, Fadel PJ. Influence of ageing on carotid baroreflex peak response latency in humans. J Physiol 587: 5427-5439, 2009.
10. Gomes VA, Casella-Filho A, Chagas AC, Tanus-Santos JE. Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide 19: 345-350, 2008.
11. Grassi G, Arenare F, Quarti-Trevano F, Seravalle G, Mancia G. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog Cardiovasc Dis 52: 31-37, 2009.
12. Grassi G, Seravalle G, Quarti-Trevano F, Mineo C, Lonati L, Facchetti R, Mancia G. Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea. J Hypertens 28: 1313-1320, 2010.
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112: 2735-2752, 2005.
14. Ichinose M, Saito M, Fujii N, Kondo N, Nishiyasu T. Modulation of the control of muscle sympathetic nerve activity during severe orthostatic stress. J Physiol 576: 947-958, 2006.
15. Joyner MJ, Charkoudian N, Wallin BG. Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications. Hypertension 56: 10-16, 2010.
16. Kara T, Narkiewicz K, Somers VK. Chemoreflexes-physiology and clinical implications. Acta Physiol Scand 177: 377-384, 2003.
17. Keyl C, Schneider A, Dambacher M, Bernardi L. Time delay of vagally mediated cardiac baroreflex response varies with autonomic cardiovascular control. J Appl Physiol 91: 283-289, 2001.
18. Kubin L, Alheid GF, Zuperku EJ, McCrimmon DR. Central pathways of pulmonary and lower airway vagal afferents. J Appl Physiol 101: 618-627, 2006.
19. Labrova R, Honzikova N, Maderova E, Vysocanova P, Novakova Z, Zavodna E, Fiser B, Semrad B. Age-dependent relationship between the carotid intima-media thickness, baroreflex sensitivity, and the inter-beat interval in normotensive and hypertensive subjects. Physiol Res 54: 593-600, 2005.
20. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
21. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110: 1245-1250, 2004.
22. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, Reid J, Van Zwieten PA. The sympathetic nervous system and the metabolic syndrome. J Hypertens 25: 909-920, 2007.
23. Martinez DG, Nicolau JC, Lage RL, Toschi-Dias E, de Matos LD, Alves MJ, Trombetta IC, Dias da Silva VJ, Middlekauff HR, Negrão CE, Rondon MU. Effects of long-term exercise training on autonomic control in myocardial infarction patients. Hypertension 58: 1049-1056, 2011.
24. Montano N, Furlan R, Guzzetti S, McAllen RM, Julien C. Analysis of sympathetic neural discharge in rats and humans. Philos Transact A Math Phys Eng Sci 367: 1265-1282, 2009.
25. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 90: 1826-1831, 1994.
26. Moraes DJ, Bonagamba LG, Zoccal DB, Machado BH. Modulation of respiratory responses to chemoreflex activation by L-glutamate and ATP in the rostral ventrolateral medulla of awake rats. Am J Physiol Regul Integr Comp Physiol 300: R1476-R1486, 2011.
27. Moraes DJ, Zoccal DB, Machado BH. Sympathoexcitation during chemoreflex active expiration is mediated by L-glutamate in the RVLM/ Botzinger complex of rats. J Neurophysiol 108: 610-623, 2012.
28. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 98: 1071-1077, 1998.
29. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99: 1183-1189, 1999.
30. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Picculuga E, Turiel M, Baselli G, Cerutti S, Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59: 178-193, 1986.
31. Pagani M, Malliani A. Interpreting oscillations of muscle sympathetic nerve activity and heart rate variability. J Hypertens 18: 1709-1719, 2000.
32. Stauss HM, Persson PB. Role of nitric oxide in buffering short-term blood pressure fluctuations. News Physiol Sci 15: 229-233, 2000.
33. Sunagawa K, Sato T, Kawada T. Integrative sympathetic baroreflex regulation of arterial pressure. Ann NY Acad Sci 940: 314-323, 2001.
34. Task Force of the European Society of Cardiology, and the North American Society of Pacing Electrophysiology. Heart rate variability: standards measurements, physiological interpretation, and clinical use. Circulation 93: 1043-1065, 1996.
35. Toschi-Dias E, Trombetta IC, da Silva VJ, Maki-Nunes C, Alves MJ, Angelo LF, Cepeda FX, Martinez DG, Negrão CE, Rondon MU. Symptoms of anxiety and mood disturbance alter cardiac and peripheral autonomic control in patients with metabolic syndrome. Eur J Appl Physiol. 2012 Aug 24. [Epub ahead of print.]
36. Trombetta IC, Maki-Nunes C, Toschi-Dias E, Alves MJ, Rondon MU, Cepêda FX, Drager LF, Braga AM, Lorenzi-Filho G, Negrão CE. Obstructive sleep apnea is associated with increased chemoreflex sensitivity in patients with metabolic syndrome. Sleep 36: 41-49, 2013.
37. Trombetta IC, Somers VK, Maki-Nunes C, Drager LF, Toschi-Dias E, Alves MJ, Fraga RF, Rondon MU, Bechara MG, Lorenzi-Filho G, Negrão CE. Consequences of comorbid sleep apnea in the metabolic syndrome-implications for cardiovascular risk. Sleep 33: 1193-1199, 2010.
38. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919-957, 1979.
39. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 95: 1449-1454, 1997.
40. Wolk R, Somers VK. Sleep and the metabolic syndrome. Exp Physiol 92: 67-78, 2007.